Bench to Bedside and Back

Preserving and restoring sight for patients suffering blinding eye disease is the core of the Duke Ophthalmology research mission.

Duke Ophthalmology aims to discover important new knowledge about biology of the eye, gain better understanding about the causes, mechanisms, diagnosis and treatment of eye disorders, translate research innovations into new care modalities and to train the next generation of researchers.

Research at Duke Ophthalmology is by no means isolated in a single laboratory or subspecialty - it’s embedded in every patient visit.  Truly “bench to bedside and back.”   The central location of the largest multi-disciplinary Duke Eye Center clinic, the Albert Eye Reserach Institute, which houses research facilities, and proximity to Duke University campus allows a multi-dimensional, approach -- making Duke Eye Center an international leader in ophthalmic research.

There are two types of research which are inter-related and continuously in progress within Duke Ophthalmology.  

 

Laboratory Research

Laboratory Research

The practice in which scientists study the disease mechanisms and possible causes and paths for diseases.
Clinical Research

Clinical Research

Patient-oriented - conducted with human participant volunteers. Clinical research involves consent and approval prior to research activities.
Contact Duke Eye Center Research

Research News

Saban receiving Cogan award

Duke Vision Scientist Receives Top Honor from ARVO

Daniel R. Saban, PhD is the recipient of the 2024 Cogan Award, presented by the Association for Research in Vision and Ophthalmology (ARVO). This prestigious award recognizes young researchers that have made significant contributions to research in ophthalmology or visual science, and that show substantial promise for future contributions in this field.   
Malek poster

Malek receives Rosalind Franklin Society Awards in Science for Journal of Ocular Pharmacology and Therapeutics

Goldis Malek, PhD, Professor in Ophthalmology, Pathology, and Cell Biology is the 2022 recipient of the RSF Awards in Science for Journal of Ocular Pharmacology and Therapeutics. This award is presented by Mary Ann Liebert, Inc. and the Rosalind Franklin Society to recognize outstanding published peer-reviewed research by women and underrepresented minorities in science. 
Lad Vice Chair

Lad named Vice Chair for Clinical Research

Duke Eye Center is proud to announce that Eleonora Lad, MD, PhD has been named Vice Chair for Clinical Research. Lad is a clinician scientist and retinal ophthalmologist with an extensive background in research, both as an investigator and in her role as Director of Clinical Research Unit (CRU).
Duke at ARVO

Duke Eye Center at ARVO 2023

The annual meeting for the Association of Research in Vision and Ophthalmology (ARVO) will be held April 23-27 in New Orleans, LA. There will be 100 presentations by Duke faculty and trainees. Paloma Liton, PhD and Anthony Kuo, MD served on the 2023 ARVO Meeting Planning Committee.  View a Full List of Duke Presentations
Lad

A New Era in Dry AMD Treatment

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved a groundbreaking treatment to treat geographic atrophy (GA), an advanced form of dry macular degeneration (AMD). Eleonora Lad, MD, PhD, director of clinical research and associate professor, was a lead investigator in the OAKS trial, a pivotal clinical trial that supported the FDA approval.